Rankings
▼
Calendar
BLTE FY 2024 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena
BLTE
Belite Bio, Inc
$7B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$40M
Net Income
-$36M
EPS (Diluted)
$-1.18
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$29M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$152M
Total Liabilities
$6M
Stockholders' Equity
$146M
Cash & Equivalents
$32M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$40M
-$32M
-26.3%
Net Income
-$36M
-$32M
-14.3%
← Q4 2023
All Quarters
Q1 2024 →